LLY

1,011.27

-2.12%↓

JNJ

243.2

-0.52%↓

ABBV

223.56

-2.05%↓

NVS

165.44

-1.33%↓

MRK

119.45

-2.56%↓

LLY

1,011.27

-2.12%↓

JNJ

243.2

-0.52%↓

ABBV

223.56

-2.05%↓

NVS

165.44

-1.33%↓

MRK

119.45

-2.56%↓

LLY

1,011.27

-2.12%↓

JNJ

243.2

-0.52%↓

ABBV

223.56

-2.05%↓

NVS

165.44

-1.33%↓

MRK

119.45

-2.56%↓

LLY

1,011.27

-2.12%↓

JNJ

243.2

-0.52%↓

ABBV

223.56

-2.05%↓

NVS

165.44

-1.33%↓

MRK

119.45

-2.56%↓

LLY

1,011.27

-2.12%↓

JNJ

243.2

-0.52%↓

ABBV

223.56

-2.05%↓

NVS

165.44

-1.33%↓

MRK

119.45

-2.56%↓

Search

Globus Medical Inc (Class A)

Открыт

СекторЗдравоохранение

96.1 1.74

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

93.3

Макс.

97.74

Ключевые показатели

By Trading Economics

Доход

-84M

119M

Продажи

24M

769M

P/E

Средняя по отрасли

30.227

108.767

Прибыль на акцию

1.18

Рентабельность продаж

15.469

Сотрудники

5,300

EBITDA

22M

215M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+17.63% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.3B

13B

Предыдущая цена открытия

94.36

Предыдущая цена закрытия

96.1

Новостные настроения

By Acuity

6%

94%

4 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

25 февр. 2026 г., 23:25 UTC

Популярные акции

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 февр. 2026 г., 23:15 UTC

Отчет

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 февр. 2026 г., 23:54 UTC

Обсуждения рынка

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 февр. 2026 г., 23:47 UTC

Отчет

Ferrovial 4Q Net EUR197M >FER.MC

25 февр. 2026 г., 23:45 UTC

Отчет

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 февр. 2026 г., 23:42 UTC

Отчет

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 февр. 2026 г., 23:38 UTC

Обсуждения рынка

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com: Company's Business Operations Remain Normal >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 февр. 2026 г., 23:25 UTC

Отчет

Trip.com FY EPS CNY47.67 >TCOM

25 февр. 2026 г., 23:06 UTC

Отчет

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 февр. 2026 г., 23:01 UTC

Отчет

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 февр. 2026 г., 23:00 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

25 февр. 2026 г., 23:00 UTC

Обсуждения рынка
Отчет

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 февр. 2026 г., 22:56 UTC

Обсуждения рынка
Отчет

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 февр. 2026 г., 22:43 UTC

Отчет
Приобретения, слияния, поглощения

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 февр. 2026 г., 22:40 UTC

Обсуждения рынка
Отчет

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 февр. 2026 г., 22:40 UTC

Отчет

Karoon Energy Says Search for New CFO Well Advanced

25 февр. 2026 г., 22:39 UTC

Отчет

Karoon Energy Says CFO Ray Church to Leave Company

25 февр. 2026 г., 22:39 UTC

Отчет

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 февр. 2026 г., 22:38 UTC

Отчет

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

17.63% рост

Прогноз на 12 месяцев

Средняя 108.08 USD  17.63%

Максимум 123 USD

Минимум 87 USD

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

14 ratings

11

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

4 / 351Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat